Skip to Content
Merck

MAB941

Anti-Coxsackievirus B4 Antibody, clone 371-3D-7H-6G

ascites fluid, clone 371-3D-7H-6G, Chemicon®

Slide 1 of 1
Sign Into View Organizational & Contract Pricing

Select a Size

Pricing and availability is not currently available.

About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

mouse

Quality Level

300

antibody form

ascites fluid

antibody product type

primary antibodies

clone

371-3D-7H-6G, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG2b

shipped in

wet ice

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
MAB985MAB8564MAB8256
Anti-Coxsackievirus B4 Antibody, clone 371-3D-7H-6G ascites fluid, clone 371-3D-7H-6G, Chemicon®

Sigma-Aldrich

MAB941

Anti-Coxsackievirus B4 Antibody, clone 371-3D-7H-6G

Anti-Echovirus 4 Antibody, clone 431-4H-6H-3B ascites fluid, clone 431-4H-6H-3B, Chemicon®

Sigma-Aldrich

MAB985

Anti-Echovirus 4 Antibody, clone 431-4H-6H-3B

Anti-Poliovirus 3 Antibody, clone 613-F1-B5-E5 ascites fluid, clone 613-F1-B5-E5, Chemicon®

Sigma-Aldrich

MAB8564

Anti-Poliovirus 3 Antibody, clone 613-F1-B5-E5

Anti-Influenza A Antibody, H1N1 Antigen, clone 9B3.2 ascites fluid, clone 9B3.2, Chemicon®

Sigma-Aldrich

MAB8256

Anti-Influenza A Antibody, H1N1 Antigen, clone 9B3.2

biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

clone

371-3D-7H-6G, monoclonal

clone

431-4H-6H-3B, monoclonal

clone

613-F1-B5-E5, monoclonal

clone

9B3.2, monoclonal

antibody form

ascites fluid

antibody form

ascites fluid

antibody form

ascites fluid

antibody form

ascites fluid

species reactivity

human

species reactivity

human

species reactivity

human

species reactivity

human

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

shipped in

wet ice

shipped in

dry ice

shipped in

dry ice

shipped in

wet ice

Application

Detect Coxsackievirus B4 using this Anti-Coxsackievirus B4 Antibody, clone 371-3D-7H-6G validated for use in IF.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Suggested starting dilution for IFA is 1:1000.

Dilute with buffer pH 7.5 -8.0 containing protein or other stabilizing medium. Final working dilutions must be determined by end user.

Biochem/physiol Actions

Reacts with Coxsackie virus B4. Neutralizes Coxsackie virus B4 JVB strain at a titer of 1:524288.

Physical form

Ascites.

Preparation Note

Maintain at -20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Persistence of coxsackievirus B4 infection in rhabdomyosarcoma cells for 30 months. Brief report.
G Frisk, M A Lindberg, H Diderholm, H Oiderholm
Archives of Virology null
Jing Dai et al.
Emerging microbes & infections, 12(2), 2261560-2261560 (2023-09-19)
Coxsackievirus B4 (CVB4) has one of the highest proportions of fatal outcomes of other enterovirus serotypes. However, the pathogenesis of severe respiratory disease caused by CVB4 infection remains unclear. In this study, 3 of 42 (7.2%, GZ-R6, GZ-R7 and GZ-R8)
Evidence for coxsackievirus infection in primary Sjogren's syndrome.
Antigoni Triantafyllopoulou, Nikos Tapinos, Haralampos M Moutsopoulos
Arthritis and Rheumatism null

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service